Increase of the epidermal growth factor receptor expression by interferon-beta

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Epidermal Growth Factor Receptor (EGF-R) is a target in cancer therapy.
• Enhancing EGF-R expression could improve antibody therapy efficacy.
• Interferon (IFN) may modulate EGF-R expression and cell proliferation.

Purpose of the Study:

• To evaluate the effects of Interferon (IFN) on EGF-R expression and cell proliferation.
• To determine if IFN-beta can enhance EGF-R expression for improved antibody targeting.
• To assess the impact of IFN-beta on tumor growth in vivo.

Main Methods:

• Screening of various IFNs on human squamous cell carcinoma cell line (HLac 79) using flow cytometry.
• Quantification of EGF-R expression and affinity via Scatchard analysis with I-125-EGF.
• Assessment of cell proliferation using bromodeoxyuridine (BrdU) assay and in vivo xenograft models (NMRI nu/nu mice).

Main Results:

• IFN-beta significantly increased EGF-R expression (doubled) in HLac 79 cells at 100 IU/ml for 48 hours.
• IFN-beta treatment resulted in a twofold increase in EGF-R expression and reduced receptor affinity in treated cells.
• IFN-beta treated xenografts showed significantly higher EGF-R levels and reduced tumor growth compared to controls.

Conclusions:

• IFN-beta effectively increases EGF-R expression in carcinoma cell lines and xenografts.
• The observed increase in EGF-R is associated with decreased cell proliferation and tumor growth.
• IFN-beta holds potential for enhancing targeted antibody therapies in cancer treatment.